Heterobifunctional inhibitors of e-selectins and cxcr4...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7034 (2006.01) A61P 35/00 (2006.01) C07H 15/207 (2006.01)

Patent

CA 2760292

Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood. More specifically, heterobifunctional compounds that inhibit both E-selectins and CXCR4 chemokine receptors are described.

L'invention porte sur des composés, des compositions et des procédés pour traiter le cancer et des maladies inflammatoires, et pour libérer des cellules telles que des cellules souches (par exemple des cellules progénitrices de moelle osseuse) dans la circulation sanguine et augmenter la rétention des cellules dans le sang. De façon plus spécifique, l'invention porte sur des composés hétérobifonctionnels qui inhibent à la fois les E-sélectines et les récepteurs aux chimiokines CXCR4.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterobifunctional inhibitors of e-selectins and cxcr4... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterobifunctional inhibitors of e-selectins and cxcr4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobifunctional inhibitors of e-selectins and cxcr4... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1396889

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.